Within the next two years, the new technology can be launched in Swedish healthcare, something that the professor believes will drastically change the diagnostic process.
"Primary care today doesn't have the right tools. Perhaps only half of those who apply for symptoms of Alzheimer's disease receive a diagnosis, or receive an incorrect diagnosis," says Oskar Hansson, chief physician in neurology at Skåne University Hospital and professor at Lund University.
He emphasizes the importance of being able to detect the disease at an early stage.
"Even at the beginning of the disease, when the affected person is aware of what is happening, it is very important that you know how to plan your life," says Hansson.
For example, people of working age can convey to their workplaces what efforts are required for them to be able to continue working.
Not for everyone
But not everyone will be able to get tested for Alzheimer's when the method is introduced. Hansson explains that it will only be recommended when you have difficulties with memory or other cognitive functions.
"This should not be used to screen healthy individuals to see if they have Alzheimer's changes in the brain and may develop problems in 10-15 years. It may be relevant in the future when we have very effective drugs that can stop the disease, but we are not there today. Now it will cause more anxiety and worry, and we can't do much about it," he says.
New antiretroviral drugs
"Diagnostics will soon become even more important when we gain access to new antiretroviral drugs, which are probably most effective at the beginning of the course of the disease," says Oskar Hansson.
It has recently been shown that the new drugs can slow down the course of the disease about 30 prcoent, according to the professor.
Hear more from Oskar Hansson about the new diagnostic process in the clip above.